NEW YORK--(BUSINESS WIRE)--
Today, Bristol-Myers
Squibb Company (NYSE: BMY) announced that Paul Biondi has been
appointed senior vice president, head of Business Development and will
report to Charlie
Bancroft, chief financial officer. In this role, Biondi will lead
the development of strategic partnerships and pursue scientific
innovations across commercial, development, discovery and technology
platforms to complement the company’s internal R&D pipeline. Biondi most
recently served as senior vice president, head of R&D Operations,
Bristol-Myers Squibb.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20151015006502/en/
Paul Biondi, Senior Vice President, Head of Business Development, Bristol-Myers Squibb (Photo: Business Wire)
“Paul has established himself as a dynamic and collaborative leader at
Bristol-Myers Squibb and made significant contributions over the past 10
years to our success in R&D and business development,” said Bancroft.
“With deep knowledge of our R&D strategy and portfolio, strong business
expertise and understanding of the healthcare landscape, Paul is the
ideal leader to continue our pursuit of external innovation that helps
Bristol-Myers Squibb develop and deliver transformational medicines for
patients with serious diseases.”
“Business development is a key component of Bristol-Myers Squibb’s
strategy, and has strengthened and diversified our portfolio for
long-term growth,” said Biondi. “We have been successful in executing
transactions that make sense strategically, scientifically and
economically for our company and partners. I look forward to leading
this high-performing team and continuing our pursuit of collaborative
partnerships and scientific innovation to help patients.”
As head of R&D Operations, Biondi led an organization focused on
optimizing delivery of the company’s pipeline, managing the company’s
R&D portfolio and project management as well as early- and late-stage
clinical operations providing strategic insights and operational
excellence across R&D. He also had responsibility for cross R&D efforts
around strategy, analytics, continuous improvement, learning and
collaboration. Biondi served a member of Bristol-Myers Squibb R&D Senior
Leadership Team, Deal Review Committee and is a member of the board of
directors of Transcelerate Biopharma Inc.
Biondi joined Bristol-Myers Squibb in 2002 and was appointed vice
president of R&D Operations when it was formed in May 2005. He was
promoted to senior vice president of R&D Operations in 2010 and has
taken on increasing levels of responsibility.
Biondi holds a bachelor’s degree in government and economics from
Dartmouth College and an M.B.A. from J.L. Kellogg School of Management
at Northwestern University.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151015006502/en/
Source: Bristol-Myers Squibb Company